Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Otto Csacsovszki"'
Autor:
Otto Csacsovszki, Attila Tordai, Hajnalka Andrikovics, András Kozma, Péter Reményi, Tamás Masszi, Gergely Varga, Katalin Piroska Kiss, Gábor Mikala, Nóra Meggyesi, Katalin Balassa, Petra Kövy, István Vályi-Nagy, András Bors
Publikováno v:
Leukemia & Lymphoma. 59:710-716
Fibroblast growth factor receptor 1 oncogene partner N-terminal like gene (FOPNL) rs72773978 polymorphism was identified as an adverse prognostic factor in multiple myeloma (MM). We aimed to investigate the associations of rs72773978 with clinical ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc432ecd12b4a639a31785d2613ca77e
https://doi.org/10.1080/10428194.2017.1346250
https://doi.org/10.1080/10428194.2017.1346250
Autor:
Gábor Mikala, Tamás Masszi, Erika Szaleczky, Gergely Varga, Árpád Illés, László Rejtő, Nóra Adamkovich, Otto Csacsovszki, Márk Plander, Hussain Alizadeh, Péter Rajnics, Zoltán Csukly, Tamás Schneider, Miklos Egyed, Zsolt Nagy, Krisztina Wolf, Nikolett Wohner, Szilvia Lovas, Ágnes Bereczki, Péter Farkas, László Váróczy, Árpád Szomor, Tamás Szendrei, Zita Borbényi
Publikováno v:
International journal of hematology. 110(5)
Daratumumab is a human anti-CD38 monoclonal antibody used in the treatment of refractory and relapsed multiple myeloma. We investigated the efficacy and safety of daratumumab therapy in a real-world setting. Ninety-nine Hungarian patients were includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0eecac2e0821f9f6a171fc1b53ebfb1
https://pubmed.ncbi.nlm.nih.gov/31392600
https://pubmed.ncbi.nlm.nih.gov/31392600
Autor:
Otto Csacsovszki, Nóra Lovas, Eniko Lehoczky, András Kozma, Péter Reményi, Tunde Krahling, Attila Tordai, Magdalena Koszarska, András Bors, Tamas Masszi, Emma Ádám, Sándor Fekete, Hajnalka Andrikovics, Nóra Meggyesi, Árpád Bátai, János Dolgos, Andrea Sipos
Publikováno v:
Leukemialymphoma. 55(7)
Internal tandem duplications (ITDs) of the fms-like tyrosine kinase 3 (FLT3) gene occur in about 25% of patients with adult acute myeloid leukemia (AML). The aim of our study was to investigate the frequency of FLT3-ITD mutations followed by a detail
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84418750319643a32d9d3f826f2b5d7d
https://pubmed.ncbi.nlm.nih.gov/24090502
https://pubmed.ncbi.nlm.nih.gov/24090502